首页> 美国卫生研究院文献>Viruses >Regulated Entry of Hepatitis C Virus into Hepatocytes
【2h】

Regulated Entry of Hepatitis C Virus into Hepatocytes

机译:丙型肝炎病毒受规管进入肝细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatitis C virus (HCV) is a model for the study of virus–host interaction and host cell responses to infection. Virus entry into hepatocytes is the first step in the HCV life cycle, and this process requires multiple receptors working together. The scavenger receptor class B type I (SR-BI) and claudin-1 (CLDN1), together with human cluster of differentiation (CD) 81 and occludin (OCLN), constitute the minimal set of HCV entry receptors. Nevertheless, HCV entry is a complex process involving multiple host signaling pathways that form a systematic regulatory network; this network is centrally controlled by upstream regulators epidermal growth factor receptor (EGFR) and transforming growth factor β receptor (TGFβ-R). Further feedback regulation and cell-to-cell spread of the virus contribute to the chronic maintenance of HCV infection. A comprehensive and accurate disclosure of this critical process should provide insights into the viral entry mechanism, and offer new strategies for treatment regimens and targets for HCV therapeutics.
机译:丙型肝炎病毒(HCV)是研究病毒与宿主相互作用和宿主细胞对感染的反应的模型。病毒进入肝细胞是HCV生命周期的第一步,这个过程需要多个受体共同作用。 B类I型清道夫受体(SR-BI)和claudin-1(CLDN1),以及人类分化簇(CD)81和occludin(OCLN),构成了HCV进入受体的最小集合。然而,HCV进入是一个复杂的过程,涉及多个宿主信号通路,形成一个系统的调控网络。该网络由上游调节剂表皮生长因子受体(EGFR)和转化生长因子β受体(TGFβ-R)集中控制。病毒的进一步反馈调节和细胞间传播有助于长期维持HCV感染。对这一关键过程的全面而准确的披露应提供对病毒进入机制的深入了解,并为HCV治疗方案和治疗方案提供新的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号